Advanced Biomed completes AI pivot with acquisition of Acellent Technologies

Advanced Biomed Inc.

Acquired 100% of Acellent Technologies (HK) for 270,000 shares at $4/share, valued at $1.08M; closed April 30, 2026.
Strategic pivot from life sciences to AI development; CEO Yi Lu mutually separated, receives 39,999 shares as severance.
Xiaomin Chen appointed CEO, director, and chairman effective April 28; he has 20+ years AI experience including Google.
Chen's base salary set at $12,000/month; eligible for bonuses and equity incentives.
Chen is the sole shareholder of the acquired entity, creating a direct material interest in the transaction.

item 2.01item 3.02item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Xiaomin Chen

Chief Executive Officer, director and Chairman of the Board

Advanced Biomed Inc.

Effective: 2026-04-28
Filed: May 01, 2026 23:59 UTC

Upon the recommendation of the Nominating and Corporate Governance Committee, the Board of Directors appointed Mr. Xiaomin Chen as Chief Executive Officer, director and Chairman of the Board of the Company, effective as of April 28, 2026.

Departed

Yi Lu

Chief Executive Officer, director and Chairman of the Board

Advanced Biomed Inc.

Successor: Xiaomin Chen
Filed: May 01, 2026 23:59 UTC

The separation of Mr. Lu from his position as Chief Executive Officer, director and Chairman of the Board is neither a resignation by Mr. Lu nor a termination by the Company (whether for cause or without cause), but rather represents a mutual agreement between the Company and Mr. Lu to effectuate a leadership transition in connection with the Strategic Pivot.

Source: SEC EDGAR

accession 0001213900-26-051028

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.